A prospective, single-arm, multicenter clinical study of a conditioning regimen containing cetipae and melphalan for the treatment of relapsed/refractory or MRD-positive acute myeloid leukemia

Authors
Category Primary study
Registry of TrialsChinese Clinical Trial Register
Year 2026
This article has no abstract
Epistemonikos ID: d0b17e33b848793a9208fb3e7a10ca1c68ff0c36
First added on: Oct 10, 2026